Data / Form D filings / Fairfield Bio, Inc.
Fairfield Bio, Inc.: Form D filing
Fairfield Bio, Inc., a company in Bronx, NY, filed a Form D with the SEC in 2026. The latest, on October 6, 2026, reports $1.9 million sold of a $3 million offering to 11 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 5454 PALISADE AVENUE, Bronx, NY, 10471
- Phone
- (646) 709-4770
- Industry
- Other
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2025
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2110597
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 6 | Amendment | $3,000,000 | $1,945,000 | $1,055,000 | 11 | Jan 26 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Kevin Slavin | Executive Officer, Director | |
| Mitchell Wolfe | Executive Officer, Director |
Other companies in New York that filed recently
- SG QC Investment, LLC $20.7 million · Oct 22
- SG QC Holdings, LLC $31.8 million · Oct 22
- Altrartis Therapeutics Inc. $11 million · Oct 22
- Axe Topco, Inc. offering · Oct 22
- MOG DEVELOPMENT Ltd LIABILITY Co offering · Oct 21
- Carter Investment Holdings, L.P. $111.8 million · Oct 21
Every Form D from the week of Oct 5 · All recent filings in New York · All recent Other filings
Read from SEC EDGAR. Amount sold is what Fairfield Bio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.